Q1 EPS Estimate for Agilent Technologies Lowered by Analyst

Agilent Technologies, Inc. (NYSE:A) – Equities researchers at Leerink Partnrs reduced their Q1 2025 earnings per share (EPS) estimates for Agilent Technologies in a note issued to investors on Tuesday, November 26th. Leerink Partnrs analyst P. Souda now anticipates that the medical research company will earn $1.28 per share for the quarter, down from their previous estimate of $1.36. The consensus estimate for Agilent Technologies’ current full-year earnings is $5.72 per share. Leerink Partnrs also issued estimates for Agilent Technologies’ Q2 2025 earnings at $1.33 EPS, Q3 2025 earnings at $1.41 EPS, Q4 2025 earnings at $1.55 EPS, FY2025 earnings at $5.57 EPS and FY2026 earnings at $6.10 EPS.

A has been the topic of several other reports. Evercore ISI upped their price objective on shares of Agilent Technologies from $135.00 to $145.00 and gave the company an “in-line” rating in a report on Tuesday, October 1st. Sanford C. Bernstein reduced their price objective on shares of Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating for the company in a research note on Tuesday. TD Cowen increased their target price on Agilent Technologies from $153.00 to $160.00 and gave the stock a “buy” rating in a research report on Thursday, August 22nd. UBS Group lifted their price target on Agilent Technologies from $141.00 to $150.00 and gave the company a “neutral” rating in a research report on Thursday, August 22nd. Finally, Stifel Nicolaus reissued a “buy” rating and set a $151.00 price objective on shares of Agilent Technologies in a report on Monday, August 26th. One equities research analyst has rated the stock with a sell rating, seven have assigned a hold rating and eight have given a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus price target of $143.40.

Agilent Technologies Trading Up 2.8 %

Shares of Agilent Technologies stock opened at $138.14 on Wednesday. The stock has a fifty day moving average price of $137.65 and a 200-day moving average price of $137.44. The company has a debt-to-equity ratio of 0.36, a current ratio of 1.78 and a quick ratio of 1.37. The firm has a market cap of $39.69 billion, a PE ratio of 28.66, a P/E/G ratio of 5.91 and a beta of 1.07. Agilent Technologies has a 1 year low of $124.10 and a 1 year high of $155.35.

Institutional Investors Weigh In On Agilent Technologies

A number of large investors have recently added to or reduced their stakes in the stock. Ancora Advisors LLC boosted its holdings in Agilent Technologies by 4.0% in the 1st quarter. Ancora Advisors LLC now owns 7,226 shares of the medical research company’s stock worth $1,051,000 after buying an additional 275 shares during the period. B. Riley Wealth Advisors Inc. boosted its holdings in Agilent Technologies by 47.9% in the 1st quarter. B. Riley Wealth Advisors Inc. now owns 5,281 shares of the medical research company’s stock worth $768,000 after buying an additional 1,711 shares during the period. California State Teachers Retirement System boosted its holdings in Agilent Technologies by 1.2% in the 1st quarter. California State Teachers Retirement System now owns 475,029 shares of the medical research company’s stock worth $69,121,000 after buying an additional 5,543 shares during the period. Tidal Investments LLC boosted its holdings in Agilent Technologies by 58.2% in the 1st quarter. Tidal Investments LLC now owns 17,447 shares of the medical research company’s stock worth $2,540,000 after buying an additional 6,420 shares during the period. Finally, iA Global Asset Management Inc. boosted its holdings in Agilent Technologies by 26.2% in the 1st quarter. iA Global Asset Management Inc. now owns 21,770 shares of the medical research company’s stock worth $3,168,000 after buying an additional 4,523 shares during the period. Institutional investors own 87.42% of the company’s stock.

Insider Buying and Selling

In related news, SVP Dominique Grau sold 9,990 shares of the firm’s stock in a transaction that occurred on Thursday, September 26th. The shares were sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the completion of the sale, the senior vice president now owns 40,011 shares of the company’s stock, valued at $5,801,595. This trade represents a 19.98 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.33% of the stock is currently owned by company insiders.

Agilent Technologies Increases Dividend

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, January 22nd. Stockholders of record on Tuesday, December 31st will be issued a dividend of $0.248 per share. This represents a $0.99 annualized dividend and a dividend yield of 0.72%. This is a positive change from Agilent Technologies’s previous quarterly dividend of $0.24. The ex-dividend date is Tuesday, December 31st. Agilent Technologies’s dividend payout ratio (DPR) is presently 20.54%.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.